KE, F., JA, K., E, H., J, L., M, D., A, A., . . . E, G. (2026). Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: Report from COG AALL15P1. Blood advances, 10(1), 70. https://doi.org/10.1182/bloodadvances.2025017013
Chicago Style (17th ed.) CitationKE, Faulk, et al. "Age-based Pegaspargase Dosing Is Safe and Achieves Therapeutic Levels in Infants with ALL: Report from COG AALL15P1." Blood Advances 10, no. 1 (2026): 70. https://doi.org/10.1182/bloodadvances.2025017013.
MLA (9th ed.) CitationKE, Faulk, et al. "Age-based Pegaspargase Dosing Is Safe and Achieves Therapeutic Levels in Infants with ALL: Report from COG AALL15P1." Blood Advances, vol. 10, no. 1, 2026, p. 70, https://doi.org/10.1182/bloodadvances.2025017013.
Warning: These citations may not always be 100% accurate.
